A class action lawsuit was filed against AbbVie for allegedly using patent thickets and colluding with biosimilar drugmakers to maintain monopoly for its blockbuster rheumatoid arthritis drug Humira, according to The Center for Biosimilars.
Pharmacy
In recent years, it has become the norm to see shortages of drugs for cancer and other diseases — and the problem is only getting worse, Yoram Unguru, MD, a pediatric hematologist and oncologist at The Herman & Walter Samuelson…
In an effort to reduce prescription drug costs in the last year, nearly one in every five patients asked their physician for a lower-cost medication, according to a new report from the CDC.
Eli Lilly received a tax abatement worth $7 million over the next 10 years with the Indianapolis City-County Council's approval, according to The Indianapolis Business Journal.
Sanofi is working to find a new CEO to succeed Olivier Brandicourt, who will reach the drugmaker's mandatory retirement age in less than two years, according to Reuters.
Advertisement
Gilead Sciences increased the U.S. prices of its top six antiviral drugs that treat HIV by 4.9 percent, according to financial and investment news site Barron's.
Ohio Attorney General Dave Yost is suing pharmacy benefit manager OptumRx to recoup $16 million in alleged overcharges, according to The Columbus Dispatch.
Pharmacy school teaches students the ins and outs of medicine, but far less about how to be an effective pharmacy leader.
While the amount of opioids prescribed per person decreased between 2006 and 2017, the average duration per opioid prescription increased, according to a new study published in JAMA.
Legacy Pharmaceuticals recalled 43 lots of losartan March 15, becoming the latest drugmaker to recall the blood pressure medication due to the detection of a potentially carcinogenic impurity.